Digital health company PneumoWave today announced the appointment of Dr Gary Cooney as Mental Health Lead.
Gary is responsible for the planning and execution of addiction and other mental health-related treatment studies using PneumoWave’s technology platform for diagnosis and monitoring of respiratory changes.
Gary is a medical doctor and consultant psychiatrist with extensive experience working with addiction and mental health issues in the NHS and private sector.
Following a BA at Harvard, Gary studied medicine at Edinburgh University.
“Gary brings extensive expertise in the field of psychiatry as we seek to integrate our technology into routine use within addictions and mental health treatment programs” said CEO Bruce Henderson.
“He will also contribute significantly to the review of datasets from our clinical research program, now underway in Dundee, Glasgow and King’s College, London, as we evaluate both physiological and behavioural data outputs to develop highly effective and easy to use solutions to reduce deaths from opioids.”
PneumoWave is a development stage digital health company based in Scotland and the US.
The company’s proprietary digital technology provides real-time physiological data and patient-centric digital biomarkers with the core focus of preventing deaths and reducing hospital admissions from respiratory causes.
Performance characteristics are not yet established.
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
Urgent work needed to tackle ‘substantial’ digital health inequality
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI6 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds